1. |
|
|
2. |
|
|
3. |
|
|
4. |
- Öberg, Kjell, et al.
(författare)
-
Neuroendocrine bronchial and thymic tumours : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- 2010
-
Ingår i: Annals of Oncology. - : Elsevier BV. - 0923-7534 .- 1569-8041. ; 21:Suppl 5, s. v220-v222
-
Tidskriftsartikel (refereegranskat)abstract
- The annual incidence of lung neuroendocrine tumour has been reported to be 1.35/100 000/year and the overall age adjusted incidence for thymic carcinoid 0.02/100 000/year. Of all neuroendocrine tumours, ∼25% are located in the respiratory tract. Both bronchial and thymic carcinoids may be part of multiple endocrine neoplasia type 1 syndrome (MEN-I) (5%–15%). The median age at diagnosis for lung neuroendocrine tumours is 64 years and for thymic tumours 59 years.
|
|
5. |
|
|
6. |
|
|
7. |
|
|